OTCMKTS:CDBT China Dasheng Biotechnology (CDBT) Stock Price, News & Analysis → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free CDBT Stock Alerts $0.02 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.0179▼$0.017950-Day Range$0.00▼$0.0452-Week Range$0.00▼$0.08VolumeN/AAverage Volume25,107 shsMarket Capitalization$160,742.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get China Dasheng Biotechnology alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About China Dasheng Biotechnology Stock (OTCMKTS:CDBT)China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, China Dasheng Biotechnology Company engages in residential and commercial real estate investment. The company was formerly known as Max Nutrition, Inc. and changed its name to China Dasheng Biotechnology Company in March 2008. China Dasheng Biotechnology Company was founded in 2004 and is based in Lanzhou, China.Read More CDBT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CDBT Stock News HeadlinesJune 5, 2023 | finanznachrichten.deChina Dasheng Biotechnology Co.: CDBT'S Transport Operations ExpandJune 5, 2023 | finance.yahoo.comCDBT'S Transport Operations ExpandApril 27, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)April 24, 2023 | seekingalpha.comCDBT to acquire Cycclone Magnetic EnginesApril 24, 2023 | finanznachrichten.deChina Dasheng Biotechnology Co.: CDBT Enters Agreement to Acquire Cycclone Magnetic Engines, Inc., the Founding Company of the Magnetic Engine ProjectApril 20, 2023 | finance.yahoo.comCycclone Magnetic Engines Acknowledges Embezzlement Allegations Against Cameron James Smith in their Transport HoldingsMarch 9, 2023 | finance.yahoo.comChina Dasheng Biotechnology Company (CDBT)February 24, 2023 | barrons.comChina Dasheng Biotechnology Co.April 27, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)February 20, 2023 | finanznachrichten.deChina Dasheng Biotechnology Co.: Cycclone Magnetic Engines Enters Work Order to Produce and Fit Y9XM EngineFebruary 20, 2023 | msn.comCycclone Magnetic Engines to produce and fit Y9XM engineFebruary 20, 2023 | finance.yahoo.comCycclone Magnetic Engines Enters Work Order to Produce and Fit Y9XM EngineFebruary 17, 2023 | finanznachrichten.deChina Dasheng Biotechnology Co.: CDBT Cycclone Magnetic Engines Acknowledges GBL ArticleFebruary 17, 2023 | finance.yahoo.comCDBT Cycclone Magnetic Engines Acknowledges GBL ArticleJanuary 26, 2023 | ft.comChina’s drug-pricing policy impedes biotech profitsJanuary 23, 2023 | finanznachrichten.deChina Dasheng Biotechnology Co.: Cycclone Magnetic Engines Limited Opens Component Development FacilityJanuary 23, 2023 | finance.yahoo.comCycclone Magnetic Engines Limited Opens Component Development FacilityNovember 15, 2022 | finance.yahoo.comNew CEO of China Dasheng Biotechnology Co. Explains the Complexities of Working in “Unproven Technologies”October 3, 2022 | finance.yahoo.comChina Dasheng Biotechnology Co. Accepts Effective Control of Cycclone Magnetic Engine Developments LimitedSeptember 9, 2022 | investing.comFTSE China A 600 - Pharmaceuticals & Biotechnology (FTXIN4201030)January 13, 2022 | nasdaq.comChina Dasheng Biotechnology Co (CDBT)See More Headlines Receive CDBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for China Dasheng Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorBasic Materials Industry Drug stores & proprietary stores Sub-IndustryN/A Current SymbolOTCMKTS:CDBT CUSIPN/A CIKN/A WebN/A Phone(424) 358-1046Fax86-93-1844-1248Employees689Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares8,980,000Free FloatN/AMarket Cap$160,742.00 OptionableNot Optionable Beta1.16 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Jinjun Qi (Age 56)President & Secretary Comp: $28kMr. Gang Chen (Age 61)Chairman of the Board & CEO Mr. Hongsheng Wang (Age 46)Chief Financial Officer Mr. Jingbo GaoVice President of Investor RelationsKey CompetitorsVolcanOTCMKTS:VOHOMexus Gold USOTCMKTS:MXSGParinga ResourcesOTCMKTS:PNRLYTamino MineralsOTCMKTS:TINOALEXIUM INTL GR/SOTCMKTS:AXXIYView All Competitors CDBT Stock Analysis - Frequently Asked Questions How have CDBT shares performed in 2024? China Dasheng Biotechnology's stock was trading at $0.0240 at the beginning of 2024. Since then, CDBT shares have decreased by 25.4% and is now trading at $0.0179. View the best growth stocks for 2024 here. How do I buy shares of China Dasheng Biotechnology? Shares of CDBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CDBT) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Dasheng Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.